Stress-induced dopaminergic (DAergic)
neuronal death in the midbrain
region is the primary cause of Parkinson’s disease (PD). Following
the discovery of l-dopa, multiple drugs have been developed
to improve the lifestyle of PD patients; however, none have been suitable
for clinical use due to their multiple side effects. Tinospora cordifolia has been used in traditional
medicines to treat neurodegenerative diseases. Previously, we reported
the neuroprotective role of Tc via inhibition of NF-κB-associated
proinflammatory cytokines against MPTP-intoxicated Parkinsonian mice.
In the present study, we investigated the neuroprotective molecular
mechanism of Tc in a rotenone (ROT)-intoxicated mouse model, using
a proteomics approach. Mice were pretreated with Tc extract by oral
administration, followed by ROT intoxication. Behavioral tests were
performed to check motor functions of mice. Protein was isolated,
and label-free quantification (LFQ) was carried out to identify differentially
expressed protein (DEP) in control vs PD and PD vs treatment groups.
Results were validated by qRT-PCR with the expression of target genes
correlating with the proteomics data. In this study, we report 800
DEPs in control vs PD and 133 in PD vs treatment groups. In
silico tools demonstrate significant enrichment of biochemical
and molecular pathways with DEPs, which are known to be important
for PD progression including mitochondrial gene expression, PD pathways,
TGF-β signaling, and Alzheimer’s disease. This study
provides novel insights into the PD progression as well as new therapeutic
targets. More importantly, it demonstrates that Tc can exert therapeutic
effects by regulating multiple pathways, resulting in neuroprotection.